Artificial intelligence techniques in inherited retinal diseases: A review
Inherited retinal diseases (IRDs) are a diverse group of genetic disorders that lead to progressive vision loss and are a major cause of blindness in working-age adults. The complexity and heterogeneity of IRDs pose significant challenges in diagnosis, prognosis, and management. Recent advancements...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Inherited retinal diseases (IRDs) are a diverse group of genetic disorders
that lead to progressive vision loss and are a major cause of blindness in
working-age adults. The complexity and heterogeneity of IRDs pose significant
challenges in diagnosis, prognosis, and management. Recent advancements in
artificial intelligence (AI) offer promising solutions to these challenges.
However, the rapid development of AI techniques and their varied applications
have led to fragmented knowledge in this field. This review consolidates
existing studies, identifies gaps, and provides an overview of AI's potential
in diagnosing and managing IRDs. It aims to structure pathways for advancing
clinical applications by exploring AI techniques like machine learning and deep
learning, particularly in disease detection, progression prediction, and
personalized treatment planning. Special focus is placed on the effectiveness
of convolutional neural networks in these areas. Additionally, the integration
of explainable AI is discussed, emphasizing its importance in clinical settings
to improve transparency and trust in AI-based systems. The review addresses the
need to bridge existing gaps in focused studies on AI's role in IRDs, offering
a structured analysis of current AI techniques and outlining future research
directions. It concludes with an overview of the challenges and opportunities
in deploying AI for IRDs, highlighting the need for interdisciplinary
collaboration and the continuous development of robust, interpretable AI models
to advance clinical applications. |
---|---|
DOI: | 10.48550/arxiv.2410.09105 |